Fennec Pharmaceuticals Inc.
General ticker "FENC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $219.6M (TTM average)
Fennec Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 15.0%.
Estimated limits based on current volatility of 2.4%: low 9.31$, high 9.77$
Factors to consider:
- Total employees count: 29 (-19.4%) as of 2023
- Top business risk factors: Operational and conduct risks, Labor/talent shortage/retention, Manufacturing and commercialization risks, Geopolitical risks, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.32$, 12.28$]
- 2026-12-31 to 2027-12-31 estimated range: [6.89$, 13.13$]
Financial Metrics affecting the FENC estimates:
- Negative: with PPE of -27.5 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Inventory ratio change, % of 0.68 <= 0.78
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Positive: 42.59 < Shareholder equity ratio, % of 50.28 <= 64.29
- Positive: Interest expense per share per price, % of 0.95 <= 3.31
- Negative: negative Net income
Short-term FENC quotes
Long-term FENC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $21.25MM | $47.54MM | $44.64MM |
| Operating Expenses | $34.31MM | $45.06MM | $50.99MM |
| Operating Income | $-13.06MM | $2.48MM | $-6.35MM |
| Non-Operating Income | $-2.99MM | $-2.55MM | $-3.29MM |
| Interest Expense | $3.39MM | $4.07MM | $2.08MM |
| R&D Expense | $0.06MM | $0.31MM | $0.25MM |
| Income(Loss) | $-16.05MM | $-0.07MM | $-9.63MM |
| Taxes | $0.00MM | $0.36MM | $0.11MM |
| Net Income(Loss)* | $-16.05MM | $-0.44MM | $-9.21MM |
| Stockholders Equity | $-11.62MM | $-5.87MM | $35.47MM |
| Inventory | $2.16MM | $1.06MM | $1.56MM |
| Assets | $26.86MM | $44.95MM | $70.55MM |
| Operating Cash Flow | $-17.14MM | $26.98MM | $-12.47MM |
| Financing Cash Flow | $6.64MM | $-13.62MM | $22.63MM |
| Earnings Per Share** | $-0.60 | $-0.02 | $-0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.